James Stambaugh, VP Clinical Affairs at Intersect ENT, Inc. (XENT), sold 500 shares at $14.38 ($7K) on 2016-06-13, disclosed to the SEC on 2016-06-14.
Open-market sale of $7k XENT by VP Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XENT | SELL | 2016-07-19 | $77K | — | Filing → |
| XENT | SELL | 2015-07-21 | $366K | — | Filing → |
| XENT | SELL | 2015-05-11 | $66K | — | Filing → |